Technology should work with both the brain and the body.
For the 1.4 billion women who navigate menstrual pain each month, relief has long meant choosing between pharmaceuticals and heating pads—solutions that address the symptom without honoring the full complexity of the experience. In May 2026, a young Shenzhen-based startup called MindGalaxy stepped into that gap in Silicon Valley, unveiling UnaBand: a wearable that fuses microcurrent brain stimulation, aromatherapy, and immersive audio into a single device premised on the idea that pain is as much a neurological event as a physical one. The launch is less a product announcement than a philosophical argument—that the body's oldest recurring discomforts may finally deserve a technology as layered as the suffering itself.
- Menstrual pain affects over a billion women monthly, yet the dominant solutions—pills with side effects and heat pads with short reach—have barely evolved in decades, leaving a vast and underserved need.
- MindGalaxy, founded just months before its debut, is wagering that targeting the brain's prefrontal cortex through synchronized electrical pulses, scent, and sound can do what pharmaceuticals alone cannot.
- The $4.7 billion menstrual wellness market is ripe for disruption, but the company enters without clinical validation in hand, making its neuroscience-forward pitch as much a provocation as a promise.
- UnaBand Pro's EEG-based closed-loop system—capable of reading brainwaves and adapting stimulation in real time—signals that the company is building toward personalization at a neurological scale.
- Pre-orders open in June 2026, placing the device at the threshold between bold concept and lived proof, where the real test of its claims will begin.
On a May afternoon in Silicon Valley, MindGalaxy—a Shenzhen startup founded just four months prior—introduced UnaBand to an audience of investors and researchers. The device is built around a single conviction: that menstrual pain is not purely muscular but neurological, and that treating it effectively means engaging the brain alongside the body.
UnaBand works by synchronizing three technologies in one wearable. Microcurrent pulses delivered through electrode-embedded fragrance cartridges target the prefrontal cortex while releasing essential oils as a fine mist. Built-in surround-sound speakers complete what the company calls a 'Brain SPA' mode, with everything managed through a companion app tracking stimulation, audio, and fragrance settings in real time.
The market context gives the launch its urgency. Roughly 1.4 billion women of reproductive age experience menstrual discomfort each month, yet the nearly $4.7 billion wellness market remains dominated by pharmaceuticals with documented side effects and heating pads that offer only temporary comfort. MindGalaxy's president, Dr. Huang Helong, acknowledged the limits of his own understanding plainly at the launch—while arguing that technology designed to work with both brain and body represents a genuinely different kind of answer.
Design was treated as a statement in itself. UnaBand was built to look like a lifestyle accessory rather than a medical device, featuring minimalist lines and what the company calls dopamine-inspired color palettes—a deliberate rejection of clinical aesthetics in personal health technology.
Looking ahead, MindGalaxy previewed UnaBand Pro, which adds EEG sensing to create a closed-loop system capable of reading brainwaves and adjusting stimulation automatically over time. Standard pre-orders open in June 2026. Clinical validation remains forthcoming, but the device already represents a considered bet that one of the body's most persistent discomforts might yield to a technology willing to take the brain seriously.
In a Silicon Valley conference room on a May afternoon, a startup that barely existed six months ago unveiled a device that its makers believe could reshape how millions of women manage one of the body's most persistent discomforts. MindGalaxy, a Shenzhen-based company founded in January 2026, introduced UnaBand to an audience of investors and researchers—a wearable that combines three separate technologies in an attempt to address menstrual pain through the brain rather than the bloodstream.
The device works by synchronizing microcurrent electrical stimulation, aromatherapy mist delivery, and immersive audio into a single wearable experience. The microcurrent pulses are delivered through electrodes embedded in fragrance cartridges, targeting the prefrontal cortex while simultaneously releasing essential oils—lavender, rose, citrus, or unscented options—as a fine mist. Built-in surround-sound speakers complete the system, all controlled through a companion app that tracks stimulation settings, audio playback, fragrance modes, and real-time data. The company calls this approach a "Brain SPA" mode, designed specifically for menstrual comfort and stress management.
The timing reflects a genuine market gap. Roughly 1.4 billion women of reproductive age experience menstrual pain each month, yet the solutions available remain largely unchanged for decades. The global menstrual wellness market is worth nearly $4.7 billion, but most of that money flows toward pharmaceuticals—many with documented side effects—or traditional heating pads that offer only temporary relief. MindGalaxy's pitch is that neither approach addresses the full picture. Pain, the company argues, is not purely physical; it involves the nervous system, mood regulation, and stress response. By targeting the brain alongside the body, UnaBand attempts to treat menstrual discomfort as a neurological event rather than merely a muscular one.
Dr. Huang Helong, MindGalaxy's president and a veteran of fourteen years in medical technology investment and management, framed the philosophy plainly during the launch: "I'm not going to pretend I fully understand menstrual pain. But I do understand that technology should work with both the brain and the body." That statement carries weight precisely because it acknowledges the limits of the company's expertise while staking a claim on a different kind of solution.
The device itself was designed to look nothing like medical equipment. Rather than the clinical white plastic of traditional wearables, UnaBand features a minimalist silhouette, premium finishes, and what the company describes as "dopamine-inspired color palettes." It is meant to be worn visibly, as a lifestyle accessory rather than a hidden medical device. This aesthetic choice reflects a broader shift in wellness technology—the idea that devices for personal health need not announce themselves as such.
MindGalaxy is already looking ahead. The company previewed UnaBand Pro, a next-generation model that incorporates EEG sensing to create what it calls a closed-loop system. This version would monitor brainwaves in real time and adjust stimulation automatically based on the user's neurological state, allowing the device to learn and adapt to individual responses over time. The upgraded app would let users visualize their own physiological responses, essentially creating a personal data dashboard for understanding how different stimulation patterns affect mood and comfort.
Pre-orders for the standard UnaBand are set to begin in June 2026. The company has positioned itself as part of the Dreame ecosystem, a broader network of consumer technology partners. Whether the device will deliver on its neuroscience-driven promises remains to be seen—clinical validation will come later, if at all. For now, UnaBand represents a bet that menstrual pain, like many forms of human suffering, might yield to a technology that treats the brain as seriously as the body.
Notable Quotes
I'm not going to pretend I fully understand menstrual pain. But I do understand that technology should work with both the brain and the body.— Dr. Huang Helong, President of MindGalaxy
UnaBand is designed to be seen, not hidden. It doesn't look like a medical device—it feels more like a personal accessory.— Dr. Huang Helong
The Hearth Conversation Another angle on the story
So they're using electrical current to stimulate the brain while releasing essential oils. That sounds like it's trying to do three things at once. Why not just pick one approach?
Because menstrual pain isn't one thing. It's physical—muscle contractions, inflammation. But it's also neurological—how your nervous system processes that pain, how stress amplifies it, how mood affects your perception of discomfort. If you only treat the muscle, you're ignoring half the problem.
But we already have medications that work on the nervous system. Why does this need to be a wearable?
Medications have side effects, and they take time to work. This is immediate, it's non-pharmaceutical, and it's personalized. You choose your fragrance, your audio, your stimulation level. It's not a one-size-fits-all pill.
The company was founded five months ago. How confident should we be that this actually works?
That's the right question. They haven't published clinical data yet. What they've done is identify a real market—1.4 billion women, $4.7 billion in spending—and offered a novel approach. Whether it works at scale is still an open question.
The Pro version with EEG sensing sounds like the real product. Is the current UnaBand just a stepping stone?
Possibly. But the current version is what they're selling now. The Pro version is a preview—a signal about where they think this technology is heading. Closed-loop brain monitoring, real-time adaptation. That's the frontier they're chasing.